A. Major Transplant Centers
The common types of bacteria include Pseudomonas, Coagulase Positive Staphylococcus, Enterobacter, Enterococcus, Streptococcus pneumoniae Acinetobacter, Hemophilus, and Klebsiella. Pneumonias occur most commonly early (within first the 2 months) and late in the transplant course (especially after the development of bronchiolitis obliterans).
The most efficacious methods to diagnose bacterial and fungal
pneumonias are listed below (in each of these culture and cytologic/histologic
examination may be performed):
When considering infectious processes, an important issue is the determination of the significance of identified microorganism. This depends on multiple factors including type of species isolated, colony count, and clinical manifestations. The diagnosis of bacterial pneumonia depends on the documentation of new fevers, infiltrates on chest radiograph, and isolation of significant numbers of the organism (generally greater than 100,000). C. Fungal infections Candida and Aspergillus are the most common fungi affecting the lung allograft. They are most common in the early period posttransplant but may occur any time afterwards. The anastomotic site is often a site of infection and this area becomes highly susceptible if dehiscence has occurred. Consequently, the infection may spread into the mediastinum to produce an abscess. While Candida mainly infests the upper tracheobronchial tree with only an occasional chance of dissemination, Aspergillus has the potential to involve the deeper parenchyma. As in the nontransplant situation, the finding of Aspergillus in specimens must be taken in the appropriate context of whether it represents colonization, allergic fungal response, or invasive disease. Other potential fungal pathogens include Cryptococcus, Pseudallerscheria and Coccidioides. D. Viral infections Cytomegalovirus (CMV) is the most common viral infection in the lung transplant population and a major cause of morbidity. Due to the high prevalence of this virus and protean manifestations, the identification of CMV must be taken in the appropriate context. CMV illness may be subdivided into CMV infection recognizing only the presence of the virus with or without associated clinical/pathological manifestations and CMV disease with recognizable clinical manifestations thought to due to the virus. To assess the appropriate risk, both the recipient and donor are tested for circulating CMV antibodies. Recipients who are serologically negative and acquire serologically negative donor lungs (R-/D-) are at the lowest risk for the development of any significant CMV disease and require only the use of CMV negative blood products when transfusion is required. On the other hand, those recipients who are serologically negative who receive serologically positive lungs (R-/D+) are at the highest risk for CMV disease and require the most aggressive anti-CMV prophylactic regimen. R+/D- and R+/D+ combinations are at intermediate risk and receive a less aggressive prophylactic regimen. Significant CMV disease occurs most commonly in the first 2 to 3 months post-transplant, although presentation may occur at anytime thereafter. Histologically, the manifestation of CMV pneumonitis ranges from a subtle patchy interstitial mononuclear cell infiltrate with rare inclusions to diffuse interstitial and perivascular neutrophilic and mononuclear cell infiltrates with alveolar damage and numerous CMV inclusions. On rare occasions, isolated CMV inclusions are found without any associated inflammation. The interpretation would depend on the clinical context; it may represent the earliest manifestation of a developing pneumonitis or the detection of a latent virus. Close followup is warranted in these circumstances. The detection of CMV by culture or Shell-vial assay alone without clinical disease or histologic confirmation indicates CMV infection without disease. On such occasions the decision for treatment would depend on the clinical situation. With the availability of current antiviral regimens, mortality from CMV pneumonitis has been relatively uncommon. CMV infection has also been associated with an increased risk for the development of chronic airway rejection (bronchiolitis obliterans). The upregulation of HLA Class II antigens following CMV infection has been postulated as a mechanism for its development. Such associations cloud the distinction between rejection and infection.
Due to prophylactic acyclovir, the incidence and morbidity from Herpes simplex pneumonia has diminished. Nevertheless, those susceptible present commonly in the first posttransplant month and the lung may be the only site of infection. Although mucocutaneous lesions may not be identified, an association between Herpes tracheitis and prolonged intubation has been noted. The histologic findings of HSV pneumonia are similar to those occurring in other immunocompromised patients. The pneumonia tends to be florid with extensive necrosis and the presence of infected cells with intranuclear ground glass inclusions and occasional Cowdry type A inclusions. Multinucleated giant cells with similar nuclear changes are also common features. Rapid treatment following its detection is critical as the disease may be fatal if left unchecked.
Adenovirus (ADV) infections have reported sporadically in the lung transplant literature. The manifestation ranges from an acute bronchitis/bronchiolitis to diffuse alveolar damage. Even in cases of DAD, a bronchocentric distribution of severe necrosis is often noted. In our series, the patients were typically young, acquired the infection within the first one and a half months post-transplant and had a rapidly fatal course. Smudgy basophilic nuclear inclusions are characteristic of ADV infections and in cases which are equivocal, the use of an immunohistochemical stain or in situ hybridization probe for ADV may be helpful. A note of importance is that an indeterminate number of patients may carry ADV subclinically without ever developing disease. The relative high incidence in the pediatric population in contrast to the adult population suggests that ADV pneumonia is a primary infection and not reactivation. Those who develop antibodies may acquire lasting immunity.
Epstein Barr virus (EBV) infections in transplant patients produces varied manifestations ranging from mononucleosis-like syndrome to posttransplant lymphoproliferative disorder (PTLD) (see below). E. Protozoal
The depressed cellular immunity provides an opportune setting for pneumocystis infection and early in the history of lung transplantation, Pneumocystis carinii pneumonia (PCP) was a common problem. However, with the institution of PCP prophylaxis (sulfonamides), the incidence of PCP has markedly diminished. Nevertheless, some patients are allergic to sulfonamides and in rare instances prophylaxis may not prevent the infection. For these reasons, diagnostic procedures (BAL culture and cytology, transbronchial and open biopsies) must include screening for pneumocystis. Immunohistochemical methods and polymerase chain reaction (PCR) may provide added sensitivity and specificity to the established methods. However, the indications for their optimal use have not been as yet determined and for the moment, morphologic and culture identification remains a sensitive, specific, and rapid modality for diagnosis. The pattern of PCP in the lung transplant recipient is similar to that in other settings. The gross appearance of the lung appears as bronchopneumonia or diffuse consolidation. Histologically, there is a range of tissue response from minimal alterations to granulomatous response and florid diffuse alveolar damage. Foamy alveolar exudates are characteristic findings on H&E sections although this appearance may be mimicked by alveolar fibrin, macrophages and other cellular debris. Therefore, the Grocott stain is indispensable in assessing the possibility of PCP and should be a component of every BAL cytology and lung biopsy workup. The typical Grocott morphology shows cup shaped cysts with central intracystic bodies. The differential diagnoses include Candida, Torulopsis, Coccidioides, Histoplasma, and Cryptosporidia. F. Some uncommon infections of interest
P. boydii is ubiquitous in the environment and produces an opportunistic infection which mimics aspergillosis both clinically and pathologically. Like aspergillus infections, the isolation of P. boydii needs to be assessed in the context of the finding. Colonization commonly occurs in the remodeled pulmonary parenchyma and cavities. On the other hand, invasive necrotizing pneumonia with abscess formation or pleural involvement with empyema may be associated with hematogenous dissemination to the brain, kidney, heart, and thyroid. A manifestation of allergic bronchopulmonary fungal disease has been also recently reported. Morphologically, P. boydii and Aspergillus are similar with both showing narrow (2 to 5 micron) septate hyphae with acute angle branching. The hyphae of P.boydii may show thin-walled vesicles with terminal conidia, features which are helpful in distinguishing it from Aspergillus. This distinction has clinical significance because amphotericin which is usually used for Aspergillosis is not an effective agent for Pseudallerscheriasis in which a miconazole or ketoconazole may be effective.
Because of the relative low prevalence of M. tuberculosis in the United States, the tuberculosis in the lung transplant population is uncommon. The diagnostic evaluation utilizes the same methodologies as in the nonimmunocompromised population. The clinical and pathologic manifestations are also protean and a certain index of suspicion is required for establishing the diagnosis. Transbronchial biopsies may only reveal nonspecific chronic inflammation and granulomas may not be present.
These gram positive aerobic, filamentous rods infect the immunocompromised or those with underlying medical conditions. The manifestations include bronchopneumonia, abscess formation, cavitation, and empyema. Furthermore, the infection may involve sites such as brain, bone, skin, and subcutaneous tissue. Eighty-five percent of nocardiosis is due to N. asteroides. The irregularly branching thin, beaded, filamentous rods are characteristic of Nocardia although from a purely morphologic point of view, Actinomyces and Streptomyces should also be considered in the differential diagnosis. While some of these cases are positive on Gram, Grocott, and Fites stain (modified Ziehl-Neehlsen) others may stain with only one or two of these stains.
Legionellosis may be community acquired or nosocomial and occurs in the settings related to contaminated heating or water supplies. While immunocompetent hosts recover from the infection, the immunocompromised patients are at a risk for high mortality. Laboratory diagnosis depends on the demonstration of organisms in tissues, secretions, or culture. Direct fluorescent antibody stain (DFA) is useful for quick diagnosis although the sensitivity may be low. Cultures provide definitive identification, although up to one week may be necessary for adequate growth. Serum antibody titers of greater than 1:256 provide presumptive evidence of Legionella pneumonia in the appropriate clinical setting. However, it should be noted that recovering individuals may still retain high antibody titers and low titers would not rule out an infection in the setting of an immunocompromised host. Histomorphologic features of Legionella pneumonia are characterized as focal lobular to confluent lobular pneumonia. Although frank necrosis and cavitation are not common, microscopic abscesses are seen frequently. The population of the inflammatory cell infiltrate ranges from predominantly neutrophilic to predominantly histiocytic with some cases showing a mixture of cell populations. Silver stains such as Dieterle, Steiner, and Warthin-Starry stains aid in the detection of the organisms on tissue sections. Immunohistochemical stains, including monoclonal preparations, may cross react with other bacterial species and therefore lack specificity. In the chronic phase, Legionella pneumonia may manifest as an organizing pneumonia or interstitial fibrosis.
Toxoplasma gondii infects humans as the intermediate host during its life cycle. Sporogeny and sexual reproduction occurs in the intestines of cats. Humans become infected by consuming the soil contaminated by feline excrement. Infection may also occur by ingestion of undercooked meats (pork, mutton, and beef). Ingested sporozoites (from oocyte) or bradyzoites (from meats) circulate in the blood and upon multiplying asexually, transform into tachyzoites. The acute phase of the infection is characterized by infected cells filled with tachyzoites ("pseudocyst") whereas the chronic phase is characterized by "tissue cysts" filled with bradyzoites. Morphologically, the infected lungs show bronchopneumonia, alveolar fibrin deposits and coagulative necrosis. Pseudocysts containing tachyzoites are seen in the alveoli with necrotic debris. For serologic diagnosis, serial tests identifying IgG and IgM against tachyzoites are required. Acute toxoplasmosis is characterized by rising antibody titers. Antitoxoplasmosis prophylaxis for recipients with negative serology acquiring organs from donors with positive serology has also contributed to the low incidence of this infection. |